156 related articles for article (PubMed ID: 10931081)
1. The somatotrophic system in patients with dilated cardiomyopathy: relation of insulin-like growth factor-1 and its alterations during growth hormone therapy to cardiac function.
Osterziel KJ; Ranke MB; Strohm O; Dietz R
Clin Endocrinol (Oxf); 2000 Jul; 53(1):61-8. PubMed ID: 10931081
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone treatment in dilated cardiomyopathy.
Perrot A; Ranke MB; Dietz R; Osterziel KJ
J Card Surg; 2001; 16(2):127-31. PubMed ID: 11766830
[TBL] [Abstract][Full Text] [Related]
3. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.
Osterziel KJ; Strohm O; Schuler J; Friedrich M; Hänlein D; Willenbrock R; Anker SD; Poole-Wilson PA; Ranke MB; Dietz R
Lancet; 1998 Apr; 351(9111):1233-7. PubMed ID: 9643742
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human growth hormone treatment for dilated cardiomyopathy in children.
McElhinney DB; Colan SD; Moran AM; Wypij D; Lin M; Majzoub JA; Crawford EC; Bartlett JM; McGrath EA; Newburger JW
Pediatrics; 2004 Oct; 114(4):e452-8. PubMed ID: 15466071
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of terminal dilated cardiomyopathy with growth hormone].
Dreifuss P
Z Kardiol; 1998 Jun; 87(6):425-35. PubMed ID: 9691412
[TBL] [Abstract][Full Text] [Related]
6. Administration of growth hormone to patients with advanced cardiac heart failure: effects upon left ventricular function, exercise capacity, and neurohormonal status.
Acevedo M; Corbalán R; Chamorro G; Jalil J; Nazzal C; Campusano C; Castro P
Int J Cardiol; 2003 Feb; 87(2-3):185-91. PubMed ID: 12559539
[TBL] [Abstract][Full Text] [Related]
7. Effects of low-dose flosequinan on left ventricular systolic and diastolic chamber performance.
Starling MR
Am Heart J; 1994 Jul; 128(1):124-33. PubMed ID: 8017265
[TBL] [Abstract][Full Text] [Related]
8. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.
Gilbert EM; Anderson JL; Deitchman D; Yanowitz FG; O'Connell JB; Renlund DG; Bartholomew M; Mealey PC; Larrabee P; Bristow MR
Am J Med; 1990 Mar; 88(3):223-9. PubMed ID: 1968710
[TBL] [Abstract][Full Text] [Related]
9. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy.
Wisenbaugh T; Katz I; Davis J; Essop R; Skoularigis J; Middlemost S; Röthlisberger C; Skudicky D; Sareli P
J Am Coll Cardiol; 1993 Apr; 21(5):1094-100. PubMed ID: 8096228
[TBL] [Abstract][Full Text] [Related]
10. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
[TBL] [Abstract][Full Text] [Related]
11. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
Tatli E; Kurum T
Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
[TBL] [Abstract][Full Text] [Related]
12. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy.
Fazio S; Sabatini D; Capaldo B; Vigorito C; Giordano A; Guida R; Pardo F; Biondi B; Saccà L
N Engl J Med; 1996 Mar; 334(13):809-14. PubMed ID: 8596546
[TBL] [Abstract][Full Text] [Related]
13. Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.
Bonnet D; Berger F; Jokinen E; Kantor PF; Daubeney PEF
J Am Coll Cardiol; 2017 Sep; 70(10):1262-1272. PubMed ID: 28859790
[TBL] [Abstract][Full Text] [Related]
14. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy.
Broglio F; Fubini A; Morello M; Arvat E; Aimaretti G; Gianotti L; Boghen MF; Deghenghi R; Mangiardi L; Ghigo E
Clin Endocrinol (Oxf); 1999 Apr; 50(4):417-30. PubMed ID: 10468900
[TBL] [Abstract][Full Text] [Related]
15. Six-months of recombinant human GH therapy in patients with ischemic cardiac failure.
van Thiel SW; Smit JW; de Roos A; Bax JJ; van der Wall EE; Biermasz NR; Viergever E; Vliegen HW; Romijn JA; Roelfsema F; Lamb HJ
Int J Cardiovasc Imaging; 2004 Feb; 20(1):53-60. PubMed ID: 15055821
[TBL] [Abstract][Full Text] [Related]
16. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study.
Eichhorn EJ; Heesch CM; Barnett JH; Alvarez LG; Fass SM; Grayburn PA; Hatfield BA; Marcoux LG; Malloy CR
J Am Coll Cardiol; 1994 Nov; 24(5):1310-20. PubMed ID: 7930255
[TBL] [Abstract][Full Text] [Related]
17. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy : effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity.
Genth-Zotz S; Zotz R; Geil S; Voigtländer T; Meyer J; Darius H
Circulation; 1999 Jan 5-12; 99(1):18-21. PubMed ID: 9884373
[TBL] [Abstract][Full Text] [Related]
18. Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy.
Hasenfuss G; Holubarsch C; Hermann HP; Astheimer K; Pieske B; Just H
Eur Heart J; 1994 Feb; 15(2):164-70. PubMed ID: 8005115
[TBL] [Abstract][Full Text] [Related]
19. Effect of metoprolol on rest and exercise left ventricular systolic and diastolic function in idiopathic dilated cardiomyopathy.
Clements IP; Miller WL
Am Heart J; 2001 Feb; 141(2):259. PubMed ID: 11174349
[TBL] [Abstract][Full Text] [Related]
20. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
Waagstein F; Strömblad O; Andersson B; Böhm M; Darius M; Delius W; Goss F; Osterziel KJ; Sigmund M; Trenkwalder SP; Wahlqvist I
Eur J Heart Fail; 2003 Oct; 5(5):679-91. PubMed ID: 14607208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
